# A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children

> **NCT01712906** · PHASE1 · COMPLETED · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 300 (actual)

## Conditions studied

- Mumps

## Interventions

- **BIOLOGICAL:** 3.50±0.25logCCID50/ml
- **BIOLOGICAL:** 4.25±0.25 logCCID50/ml
- **BIOLOGICAL:** 5.00±0.25 logCCID50/ml
- **BIOLOGICAL:** 0 logCCID50/ml
- **BIOLOGICAL:** Attenuated Mumps vaccine (Zhe Jiang Vacn Bio-pharmaceutical Co., LTD.; NO.20110528-1)

## Key facts

- **NCT ID:** NCT01712906
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01712906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01712906, "A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01712906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*